Net Margin - Hofseth Biocare ASA (OSE:HBC) - Alpha Spread

Hofseth Biocare ASA
OSE:HBC

Watchlist Manager
Hofseth Biocare ASA Logo
Hofseth Biocare ASA
OSE:HBC
Watchlist
Price: 1.705 NOK -4.21% Market Closed
Market Cap: 610.1m NOK
Have any thoughts about
Hofseth Biocare ASA?
Write Note

Net Margin
Hofseth Biocare ASA

-43.3%
Current
-109%
Average
-7.7%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-43.3%
=
Net Income
-97.9m
/
Revenue
226.1m

Net Margin Across Competitors

Country NO
Market Cap 673.6m NOK
Net Margin
-43%
Country US
Market Cap 341.9B USD
Net Margin
10%
Country US
Market Cap 180.5B USD
Net Margin
10%
Country US
Market Cap 127.8B USD
Net Margin
32%
Country US
Market Cap 123.3B USD
Net Margin
-5%
Country US
Market Cap 104.5B USD
Net Margin
4%
Country US
Market Cap 94.1B EUR
Net Margin
-392%
Country AU
Market Cap 142.3B AUD
Net Margin
18%
Country US
Market Cap 39.3B EUR
Net Margin
-33%
Country US
Market Cap 38.5B USD
Net Margin
-557%
Country US
Market Cap 35.4B USD
Net Margin
-3%

Profitability Report

View the profitability report to see the full profitability analysis for Hofseth Biocare ASA.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-43.3%
=
Net Income
-97.9m
/
Revenue
226.1m
What is the Net Margin of Hofseth Biocare ASA?

Based on Hofseth Biocare ASA's most recent financial statements, the company has Net Margin of -43.3%.